Author:
de Pinho Favaro Marianna Teixeira,Atienza-Garriga Jan,Martínez-Torró Carlos,Parladé Eloi,Vázquez Esther,Corchero José Luis,Ferrer-Miralles Neus,Villaverde Antonio
Abstract
AbstractThe last big outbreaks of Ebola fever in Africa, the thousands of avian influenza outbreaks across Europe, Asia, North America and Africa, the emergence of monkeypox virus in Europe and specially the COVID-19 pandemics have globally stressed the need for efficient, cost-effective vaccines against infectious diseases. Ideally, they should be based on transversal technologies of wide applicability. In this context, and pushed by the above-mentioned epidemiological needs, new and highly sophisticated DNA-or RNA-based vaccination strategies have been recently developed and applied at large-scale. Being very promising and effective, they still need to be assessed regarding the level of conferred long-term protection. Despite these fast-developing approaches, subunit vaccines, based on recombinant proteins obtained by conventional genetic engineering, still show a wide spectrum of interesting potentialities and an important margin for further development. In the 80’s, the first vaccination attempts with recombinant vaccines consisted in single structural proteins from viral pathogens, administered as soluble plain versions. In contrast, more complex formulations of recombinant antigens with particular geometries are progressively generated and explored in an attempt to mimic the multifaceted set of stimuli offered to the immune system by replicating pathogens. The diversity of recombinant antimicrobial vaccines and vaccine prototypes is revised here considering the cell factory types, through relevant examples of prototypes under development as well as already approved products.
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Ministerio de Ciencia, Innovación y Universidades
Instituto de Salud Carlos III
Agencia Estatal de Investigación
Agència de Gestió d'Ajuts Universitaris i de Recerca
Universitat Autònoma de Barcelona
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference238 articles.
1. Thomas S, Abraham A, Rodríguez-Mallon A, Unajak S, Bannantine JP. Challenges in Veterinary Vaccine Development. In: Thomas S, editor. Vaccine Design: Methods and Protocols, Volume 2 Vaccines for Veterinary Diseases. New York: Springer; 2022. p. 3–34.
2. Mascola JR, Fauci AS. Novel vaccine technologies for the 21st century. Nat Rev Immunol. 2020;20:87–8.
3. Levine MM, Sztein MB. Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol. 2004;5:460–4.
4. Moyle PM, Toth I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem. 2013;8:360–76.
5. Tsoras AN, Champion JA. Protein and peptide biomaterials for engineered subunit vaccines and immunotherapeutic applications. Annu Rev Chem Biomol Eng. 2019;10:337–59.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献